We are live on
!
Find out more
GCM
Gladius Capital Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
25.75%
This Fund
S&P 500
This Quarter
Est. Return
-7.54%
1 Year Est. Return
+25.75%
3 Year Est. Return
+78.03%
5 Year Est. Return
+67.88%
10 Year Est. Return
+218.88%
AUM
$2.27B
AUM Growth
+$344M
(+18%)
Cap. Flow
+$575M
Cap. Flow
% of AUM
25.32%
Top 10 Holdings %
Top 10 Hldgs %
66.6%
Holding
527
New
179
Increased
107
Reduced
74
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$61.5M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$58M |
| 3 |
Microsoft
MSFT
|
+$47.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$46.4M |
| 5 |
Boeing
BA
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$36.1M |
| 2 |
Caterpillar
CAT
|
+$17.4M |
| 3 |
Netflix
NFLX
|
+$17M |
| 4 |
Walmart Inc
WMT
|
+$14.8M |
| 5 |
Salesforce
CRM
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Industrials | 1.27% |
| 3 | Healthcare | 1.27% |
| 4 | Consumer Discretionary | 1.23% |
| 5 | Financials | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
SPDR Gold Trust
GLD
$138B
| $31K | ﹤0.01% |
200
| – | – |
|
|
ITOS
302
DELISTED
iTeos Therapeutics
ITOS
| $31K | ﹤0.01% |
+1,586
| New | +$36.5K |
|
303
Primoris Services
PRIM
$4.35B
| $31K | ﹤0.01% |
+1,890
| New | +$39.5K |
|
304
Universal Technical Institute
UTI
$1.53B
| $31K | ﹤0.01% |
+5,663
| New | +$39.6K |
|
305
Elanco Animal Health
ELAN
$12.1B
| $30K | ﹤0.01% |
2,384
+1,413
| +146% | +$24.7K |
|
|
KRON
306
DELISTED
Kronos Bio
KRON
| $30K | ﹤0.01% |
+8,782
| New | +$39.6K |
|
|
MRC
307
DELISTED
MRC Global
MRC
| $30K | ﹤0.01% |
+4,053
| New | +$39.9K |
|
308
Nuvation Bio
NUVB
$2.13B
| $30K | ﹤0.01% |
+13,222
| New | +$37.8K |
|
309
Organon & Co
OGN
$3.56B
| $30K | ﹤0.01% |
+1,246
| New | +$37.6K |
|
310
Sylvamo
SLVM
$1.5B
| $30K | ﹤0.01% |
+871
| New | +$33.1K |
|
311
Smith & Wesson
SWBI
$651M
| $30K | ﹤0.01% |
2,873
-8,168
| -74% | -$108K |
|
312
Vir Biotechnology
VIR
$1.48B
| $30K | ﹤0.01% |
+1,529
| New | +$38.9K |
|
|
EGRX
313
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $30K | ﹤0.01% |
+1,127
| New | +$41.4K |
|
314
Atea Pharmaceuticals
AVIR
$399M
| $28K | ﹤0.01% |
+4,849
| New | +$37.1K |
|
315
Distribution Solutions Group
DSGR
$1.61B
| $28K | ﹤0.01% |
1,968
-1,902
| -49% | -$41.2K |
|
|
LNAI
316
Lunai Bioworks
LNAI
$11M
| $28K | ﹤0.01% |
+190
| New | +$34.6K |
|
|
TRUE
317
DELISTED
TrueCar
TRUE
| $28K | ﹤0.01% |
18,457
+14,908
| +420% | +$34K |
|
318
Wheels Up
UP
$197M
| $25K | ﹤0.01% |
+106
| New | +$42.5K |
|
|
ICVX
319
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $25K | ﹤0.01% |
+7,828
| New | +$49K |
|
320
Watsco Inc
WSO
$13.2B
| $24K | ﹤0.01% |
90
-80
| -47% | -$21.7K |
|
321
Advantage Solutions
ADV
$337M
| $23K | ﹤0.01% |
+431
| New | +$39.7K |
|
|
FATH
322
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $23K | ﹤0.01% |
+543
| New | +$37.3K |
|
|
VWE
323
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $19K | ﹤0.01% |
+6,595
| New | +$39.3K |
|
324
Brookfield Renewable
BEPC
$6.19B
| $15K | ﹤0.01% |
+454
| New | +$17.5K |
|
325
Cohu
COHU
$2.45B
| $15K | ﹤0.01% |
+556
| New | +$15.4K |
|
Similar funds
ACM
CCM
BFPW
RIA
GACM
GA
LIA
Gladius Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Gladius Capital Management held 527 positions worth $2.27B, up 18% from $1.93B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Gladius Capital Management deployed $575M of net new capital in Q3 2022, opening 179 new positions and adding to 107 existing holdings. Its largest new stake was Goldman Sachs: 34,926 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 3.1% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $36.1M trimmed.
- Gladius Capital Management's largest Q3 2022 buy was Goldman Sachs: 34,926 shares worth $10.2M.
- Gladius Capital Management added most to Apple in Q3 2022, an estimated $61.5M increase.
- Gladius Capital Management's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $36.1M.
- Gladius Capital Management fully exited Caterpillar in Q3 2022, selling an estimated $17.4M.
- Gladius Capital Management's ten largest holdings make up 67% of its $2.27B portfolio in Q3 2022.
- Gladius Capital Management opened 179 new positions and closed 161 in Q3 2022.
- Gladius Capital Management's portfolio value rose 18% quarter-over-quarter to $2.27B.
Based on Gladius Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.